Risk Based Monitoring- a data-centric approach to monitoring
The outbreak and spread of the COVID-19 (SARS-CoV-2) pandemic continues to have a significant negative impact on the clinical trials industry. Restrictions to curb the spread of the virus caused many sites to be temporarily closed to external visits and resulted in postponements and delays to trials. In spite of these challenges, the industry has
Cromos Pharma Recruits over 300 Patients in Under Two Months into a COVID-19 Clinical Trial
June 18, 2020 – Portland, OR. Cromos Pharma, an international CRO, is pleased to announce unprecedented recruitment in a phase IIb trial in patients with moderate to severe COVID-19 infection. It has successfully recruited over 300 patients in under two months to the trial. “We are very proud of our team for this fantastic accomplishment,”
Watch our webinar: Your Trial Post-Covid: Recovery Must Start Now
This webinar, hosted by Cromos Pharma with MKR Clinical Research Consultants (29 May 2020), explores strategic approaches to getting clinical trials back on track amid the ongoing COVID-19 pandemic. It also featured insights into optimal country choices to maximize enrolment as regions begin to reopen and lift pandemic restrictions. “Using a scenario-based modelling approach the Cromos
